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Studies of the identity and physiological function
of mesenchymal stromal cells (MSCs) have been
hampered by a lack of markers that permit both pro-
spective identification and fate mapping in vivo. We
found that Leptin Receptor (LepR) is a marker that
highly enriches bone marrow MSCs. Approximately
0.3% of bone marrow cells were LepR+, 10% of
which were CFU-Fs, accounting for 94% of bone
marrow CFU-Fs. LepR+ cells formed bone, cartilage,
and adipocytes in culture and upon transplantation
in vivo. LepR+ cells were Scf-GFP+, Cxcl12-
DsRedhigh, and Nestin-GFPlow, markers which also
highly enriched CFU-Fs, but negative for Nestin-
CreER and NG2-CreER, markers which were unlikely
to be found in CFU-Fs. Fate-mapping showed
that LepR+ cells arose postnatally and gave rise to
most bone and adipocytes formed in adult bone
marrow, including bone regenerated after irradiation
or fracture. LepR+ cells were quiescent, but they
proliferated after injury. Therefore, LepR+ cells are
the major source of bone and adipocytes in adult
bone marrow.
INTRODUCTION
Multipotent mesenchymal stromal cells (MSCs) have been
defined in culture as nonhematopoietic, plastic-adherent, col-
ony-forming cells, referred to as colony-forming unit-fibroblasts
(CFU-Fs), that can differentiate into osteogenic, chondrogenic,
and adipogenic progeny (Bianco et al., 2008; Friedenstein
et al., 1970; Horwitz et al., 2005; Pittenger et al., 1999). A funda-
mental question concerns the identity of the cells that form CFU-
Fs in culture and their physiological function in vivo.
In vivo, MSCs are often perivascular (Crisan et al., 2008; Sac-
chetti et al., 2007). In human tissues, MSCs have been prospec-
tively identified based on the lack of expression of endothelial
and hematopoietic markers along with positive expression for
CD146 (Sacchetti et al., 2007) or CD146 with platelet-derived
growth factor receptor b (PDGFRb), CD106, NG2, or some com-
bination thereof (Chou et al., 2012; Crisan et al., 2008; Schwab154 Cell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc.and Gargett, 2007). CD146+ MSCs from human bone marrow
form osteogenic, chondrogenic, and adipogenic cells in culture
and give rise to bone upon transplantation in vivo, forming bony
ossicles that become invested with hematopoietic bone marrow
(Sacchetti et al., 2007). The CD146+ cells persist around sinusoi-
dal blood vessels in the ossicles and express HSC niche factors.
Ectopic bones that become invested with bone marrow can also
be formed byCD105+Thy1mesenchymal cells from fetalmouse
bones (Chan et al., 2009). Althoughmuch has been learned about
the localization and developmental potential of MSCs, limitations
in the ability to fate-map these cells in vivo have hindered our un-
derstanding of their normal physiological function.
Mouse MSCs have been prospectively identified based on the
lack of expression of hematopoietic and endothelial markers and
positive expression of PDGFRa (Morikawa et al., 2009;
Omatsu et al., 2010; Park et al., 2012). The PDGFRa+Sca-1+
CD45Ter119 subset of cells appears to reside primarily
around arterioles but does not express the hematopoietic
stem cell (HSC) niche factor Cxcl12, while PDGFRa+
Sca-1CD45Ter119 cells that express high levels of Cxcl12,
also known as CXCL12-abundant reticular (CAR) cells, reside
primarily around sinusoids (Morikawa et al., 2009; Omatsu
et al., 2010). CAR cells include bipotent progenitors of osteo-
blasts and adipocytes (Omatsu et al., 2010). Ablation of CAR
cells with diphtheria toxin (DT) depletes not only adipogenic
and osteogenic progenitors, but also HSCs (Omatsu et al.,
2010). These data suggest that MSCs within the bone marrow
are a cellular component of the HSC niche.
Cells that express the Nestin-GFP transgene contain all of the
CFU-Fs in mouse bone marrow (Kunisaki et al., 2013; Me´ndez-
Ferrer et al., 2010). These cells also express high levels of the
HSC niche factors Cxcl12 and Stem cell factor (Scf) (Kunisaki
et al., 2013; Me´ndez-Ferrer et al., 2010). Nestin-CreER-express-
ing cells in adult bone marrow can contribute to osteoblasts and
chondrocytes, though no quantification was provided regarding
their CFU-F content or their level of contribution to new bone
(Me´ndez-Ferrer et al., 2010). Nestin-GFP is widely expressed
by perivascular stromal cells in the bone marrow, but they
express little endogenous Nestin, Nestin-CreER, or other Nestin
transgenes (Ding et al., 2012). Furthermore, Nestin-GFP+ cells
are heterogeneous, including both Nestin-GFPhigh cells that
localize mainly around arterioles and Nestin-GFPlow cells that
localize mainly around sinusoids, raising questions about the
distribution of HSC niche factors and MSCs among these cell
populations (Kunisaki et al., 2013).
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Leptin Receptor Marks Bone Marrow MSCsDuring fetal development, Osterix (Osx) is expressed by cells
that form bone marrow stroma, including perivascular, osteo-
genic, and adipogenic cells (Liu et al., 2013; Maes et al., 2010).
In adult bone marrow, Osx is expressed by a subset of CAR cells
(Omatsu et al., 2010), and fate mapping of these cells usingOsx-
CreER revealed a transient contribution to osteoblasts (Park
et al., 2012). In contrast, Mx-1-Cre recombined widely among
hematopoietic cells, PDGFRa+ stromal cells, and CFU-Fs in
the bone marrow, and these cells gave rise to most of the oste-
oblasts formed in adult bone marrow (Park et al., 2012). The
widespread marking of both hematopoietic and stromal cells
by Mx-1-Cre meant that this marker could not be used to pro-
spectively identify osteogenic progenitors.
Recently, we identified Leptin Receptor+ (LepR+) perivascular
stromal cells that are the major source of Scf and Cxcl12 in the
bone marrow (Ding and Morrison, 2013; Ding et al., 2012). Con-
ditional deletion of Scf with Lepr-Cre led to the depletion of
quiescent HSCs (Ding et al., 2012; Oguro et al., 2013) and con-
ditional deletion of Cxcl12with Lepr-Cre led to HSCmobilization
(Ding and Morrison, 2013). Here we show that LepR+ cells are
highly enriched for CFU-F and uniformly express Prx1-Cre,
PDGFRa, and CD51, markers expressed by bone marrow
MSCs. LepR+ cells were the main source of new osteoblasts
and adipocytes in adult bone marrow and could form bony
ossicles that support hematopoiesis in vivo. In contrast,
Wnt1-Cre-expressing neural-crest-derived cells and Nestin-
CreER-expressing cells included few CFU-Fs and made little
contribution to adult osteogenesis.
RESULTS
LepR+ BoneMarrow Stromal Cells Are Around Sinusoids
and Arterioles
Sections from wild-type mice exhibited perivascular LepR
staining throughout the bone marrow, around both sinusoids
and arterioles (Figures 1A, 1C, and 1D). The staining was in peri-
vascular stromal cells that expressed the HSC niche factor Scf
(Figure 1C). An antibody against the LepR extracellular domain
stained in a pattern very similar to that of Tomato expression in
Lepr-cre; tdTomato conditional reporter mice (Figure 1D). Ubc-
creER; Leprfl/fl mice that had been treated with tamoxifen for
1 month to conditionally delete Lepr had little staining with
the antibody in sections (Figure 1B) or in PDGFRa+
CD45Ter119CD31 bone marrow stromal cells analyzed by
flow cytometry (Figure S1A available online).
We identified sinusoids and arterioles based on VE-Cadherin
(VE-Cad) staining, which bound endothelial cells in both sinu-
soids and arterioles, and SM22 staining, which specifically
marked vascular smooth muscle around arterioles. Sinusoids
were typically larger in diameter, less uniform, and thinner walled
as compared to arterioles (Figure 1E). We observed LepR+ cells
around both sinusoids and arterioles throughout the bone
marrow, though LepR+ cells were much more prominent around
some arterioles than others (Figure 1E). Nearly all the perisinusoi-
dal LepR+ cells were Scf-GFP+; however, the periarteriolar
LepR+ cells, especially those densely surrounding larger arteri-
oles, expressed less Scf-GFP (Figure 1E). The LepR+ cells
around arterioles were negative for SM22 or aSMA (Figures 1E
and S1C).CWe observed little LepR antibody staining in CD45+ or Ter119+
hematopoietic cells (Figure 1F) or in VE-Cad+ bone marrow
endothelial cells (Figures 1A, 1E, and 1G). The rare LepR anti-
body staining that was observed in these cells may reflect the
expression of short isoforms of Lepr that lack the intracellular
signaling domain (Ob–Ra, Ob–Rc, Ob–Rd, and Ob–Re). These
isoforms are somewhat more broadly expressed than the Ob–
Rb isoform, which encodes full-length LepR, including the intra-
cellular signaling domain. It is this full-length isoform whose
expression is marked by Lepr-cre. Little recombination was
observed inmacrophages (Figure S1D) or in other hematopoietic
cells (Figure 1M) using Lepr-cre.
Consistent with the lack of EYFP expression in bone-lining
cells from 2-month-old Lepr-cre; EYFP reporter mice (Ding
et al., 2012), we were unable to detect LepR antibody staining
in Col2.3-GFP+ osteoblastic cells from cortical or trabecular
bone in 2-month-old mice (Figure 1H). Neither Aggrecan+ artic-
ular cartilage cells in the femur (knee joint; Figure 1I) nor Perilipin+
fat cells in the bone marrow (Figure 1J) exhibited LepR antibody
staining. Thus, at 2 months of age, LepR expression was largely
restricted to perivascular stromal cells and not to more differen-
tiated mesenchymal derivatives in bone marrow.
Consistent with the LepR antibody staining and Lepr-cre;
tdTomato conditional reporter expression pattern, quantitative
real-time PCR (qPCR) showed that full-length Ob-Rb transcripts
were at 100- to 1,000-fold higher levels in PDGFRa+
CD45Ter119CD31 perivascular stromal cells as compared
to unfractionated bone marrow cells, Col2.3-GFP+CD45
Ter119 osteoblastic cells, and VE-Cad+CD45Ter119 bone
marrow endothelial cells (Figure 1K). Virtually all LepR+ cells
expressed Scf-GFP and nearly all Scf-GFP+ cells expressed
LepR (Figure S1E). LepR+ Scf-GFP cells around certain arteri-
oles appeared to represent <1% of LepR+ cells in bone marrow
(Figure 1E). Nearly all LepR+ cells expressed high levels of
Cxcl12-DsRed and nearly all cells that expressed high levels of
Cxcl12-DsRed expressed LepR (Figure S1F). Most LepR+ cells
expressed low levels of Nestin-GFP (Figures S1G and S1H),
consistent with a recent report (Kunisaki et al., 2013). Cells that
expressed high levels of Nestin-GFP did not stain with either
LepR or PDGFRa (Figure S1H). The vast majority of bonemarrow
cells that express high levels of HSC niche factors and the bone
marrow MSC marker PDGFRa are thus LepR+.
LepR+CD45Ter119 bone marrow stromal cells accounted
for 0.2% to 0.3% of enzymatically dissociated bone marrow
cells, irrespective of whether these cells were identified by
LepR antibody staining (Figure 1L) or Tomato expression in
Lepr-cre; tdTomato conditional reporter mice (Figure 1M). Nearly
all LepR+CD45Ter119CD31 bone marrow stromal cells
were positive for PDGFRa and nearly all PDGFRa+CD45
Ter119CD31 bone marrow cells were LepR+ (Figures 1L
and 1M). These data suggested that LepR+ bonemarrow stromal
cells might be highly enriched for MSCs. Consistent with
this possibility, we found that LepR+CD45Ter119CD31
bone marrow stromal cells were uniformly positive for the MSC
markers CD51 (Pinho et al., 2013) and PDGFRb (Komada et al.,
2012) (Figure 1N). Approximately 68% of LepR+CD45
Ter119 cells were positive for the MSC marker CD105 (Chan
et al., 2009; Park et al., 2012) (Figure 1N). LepR+CD45Ter119
cells were heterogeneous for Sca-1 (Figure 1N), which isell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc. 155
(legend on next page)
Cell Stem Cell
Leptin Receptor Marks Bone Marrow MSCs
156 Cell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc.
Cell Stem Cell
Leptin Receptor Marks Bone Marrow MSCsexpressed by a subset of MSCs (Morikawa et al., 2009; Omatsu
et al., 2010).
LepR+ Cells Are the Main Source of CFU-Fs in Bone
Marrow
To assess CFU-F activity we enzymatically dissociated bone
marrow cells and added them to adherent cultures at clonal
density. Figure 2B shows the percentage of cells in each cell
population sorted from unfractionated bone marrow cells
(including both hematopoietic and stromal elements) that formed
CFU-F colonies in culture. Figure 2C shows the percentage of
cells in each cell population sorted from nonhematopoietic
(CD45Ter119) bone marrow stromal cells that formed CFU-F
colonies in culture. In our experiments, 0.012% ± 0.002% of all
enzymatically dissociated bone marrow cells (Figure 2B) or
1.3% ± 0.5% of CD45Ter119 bone marrow stromal cells
formed CFU-F colonies (Figure 2C).
Consistent with a prior study (Morikawa et al., 2009), 9.8% ±
5.0% of PDGFRa+CD45Ter119 bone marrow stromal cells,
15.6% ± 3.0% of PDGFRa+Sca-1+CD45Ter119 bone marrow
stromal cells, and 8.3% ± 5.2% of PDGFRa+Sca-1
CD45Ter119 bone marrow stromal cells formed CFU-F
colonies (Figure 2C). Although PDGFRa+Sca-1+ stromal cells
were more highly enriched for CFU-F activity than PDGFRa+
Sca-1 cells (Figure 2C), PDGFRa+Sca-1 stromal cells con-
tainedmost of theCFU-F activity in the bonemarrow (Figure S2A)
because they were much more abundant than PDGFRa+Sca-1+
cells (0.22% ± 0.08% versus 0.03% ± 0.02% of bone marrow
cells; Figures 1N and S1J). PDGFRa+ bone marrow cells are
thus highly enriched for CFU-F, but we could not fate map
PDGFRa+ cells because Pdgfra-CreER (Rivers et al., 2008) re-
combined poorly in bone marrow PDGFRa+ cells (data not
shown).
The vast majority of bone marrow CFU-Fs derive from LepR+
cells. In CFU-F colonies formed by bone marrow cells from
Lepr-cre; tdTomato mice, 94% ± 4% were Tomato+ (Figures
2A and S2B–S2E). In 2- to 4-month-old Lepr-cre; tdTomatoFigure 1. LepR and Scf-GFP-Expressing Cells Are Abundant around S
Stromal Cells
(A and B) Representative femur sections from 3- to 4-month-old wild-type (A) and
in wild-type (A) but not Ubc-creER; Leprfl/fl (B) bone marrow (unless otherwise in
pendent experiments).
(C) Staining with anti-LepR antibody and Scf-GFP.
(D) Staining with anti-LepR antibody strongly overlapped with Tomato expr
tdTomato mice.
(E) 3D reconstruction of a Z stack of tiled confocal images of femur bone marro
sinusoids (arrowheads, left panel) and arterioles while anti-SM22 staining specifica
from the same field of view. LepR was expressed by perivascular cells around s
sinusoids. Note that most Scf-GFP staining that did not overlap with Tomato stain
their cell body (see Figure S1B). The frequency of Scf-GFP+ cells appears high in
single optical section.
(F and G) Flow cytometry analysis showed that CD45/Ter119+ hematopoietic ce
bone marrow was dissociated mechanically in (F) (thus lacking stroma) or enzym
(H–J)Col2.3-GFP+ osteoblasts (H), Aggrecan+ chondrocytes (I), and Perilipin+ adip
independent experiments.
(K) Quantitative RT-PCR of Ob–Rb transcript levels (normalized to b-Actin). Data
(L and M) In 2- to 4-month-old mice, nearly all LepR+ bone marrow cells stained
were identified by antibody staining (L) or Tomato expression in Lepr-cre; tdTom
independent experiments.
(N) Marker expression by Tomato+ bone marrow cells from Lepr-cre; tdTomato m
Cmice, 8.5% ± 2.5% of all Tomato+ bone marrow cells (Figure 2B)
and 11% ± 3.5% of Tomato+CD45Ter119 bone marrow stro-
mal cells formed CFU-F colonies (Figure 2C), whereas only
0.10% ± 0.08% of TomatoCD45Ter119 bone marrow stro-
mal cells formed CFU-F colonies (Figure 2C). Consistent with a
previous study (Park et al., 2012), almost all of the Tomato+
CFU-Fs in Lepr-cre; tdTomato bone marrow were CD105+ (Fig-
ure 2C). Cells derived from full-length LepR+ cells in the bone
marrow were thus as highly enriched for CFU-Fs as PDGFRa+
CD45Ter119 bone marrow cells.
We split cells obtained from individual CFU-F colonies formed
by LepR+ cells into three aliquots and subcloned them into
cultures that promoted bone, cartilage, or fat cell differentiation.
In CFU-F colonies formed by Tomato+ bone marrow cells from
Lepr-cre; tdTomato mice, 8.9 ± 4.5% underwent multilineage
differentiation (Figure 2D), giving rise to Alizarin-red-S-stained
osteoblastic cells (Figures S2F and S2G), Oil-red-O-stained ad-
ipocytes (Figures S2H and S2I), and Toluidine-blue-stained
chondrocytic cells (Figures S2J and S2K). Most of the remaining
CFU-F colonies formed by Tomato+ cells differentiated to oste-
oblastic cells with or without chondrocytic cells or fat cells. Over-
all, 58% ± 17% of all CFU-F colonies formed by Tomato+ cells
formed osteoblastic cells in culture.
We also sorted individual LepR+ cells from Lepr-cre;
tdTomato; Col2.3-GFP mice into culture, allowed them to form
CFU-F colonies, then expanded individual colonies, implanted
the cells into denatured collagen sponges, transplanted them
subcutaneously, and assessed the development of bony
ossicles and hematopoiesis 8 weeks later. The presence of
hematopoiesis was determined based on the presence of undif-
ferentiated and differentiated erythroid, myeloid, and lymphoid
cells in ossicle sections. Fourteen of twenty-five sponges did
not form bone. Of the 11 that did form bone, we detected hema-
topoiesis in 8 (Figures 2D and S2L–S2N), 3 of which had abun-
dant hematopoiesis that resembled bone marrow and 5 of which
had smaller foci of hematopoietic cells distributed throughout
each ossicle. In each case, we observed donor-derivedinusoids throughout the Bone Marrow and Are Distinct from Other
Ubc-creER; Leprfl/flmice (B). The anti-LepR antibody stained perivascular cells
dicated, each panel reflects data from three mice/genotype from three inde-
ession around sinusoids and arterioles in the bone marrow of Lepr-cre;
w from a Lepr-cre; tdTomato; Scf-GFP mouse. Anti-VE-Cad staining marked
llymarked arterioles (arrows, left panel). Left and right panels represent images
inusoids and arterioles, but LepR+Scf-GFP+ cells were most abundant around
ing represented the processes of perivascular cells that had Tomato staining in
this image because it represents a Z stack of images from a thick section, not a
lls (F) and VE-Cad+ endothelial cells (G) rarely stained positively for LepR. The
atically in (G) (including stroma).
ocytes (J) did not stain with anti-LepR antibody. n = 3–5mice from at least three
represent mean ± SD (standard deviation) from four independent experiments.
positively for PDGFRa, and vice versa, irrespective of whether the LepR+ cells
ato mice (M). The data represent mean ± SD from 3–5 mice from at least three
ice.
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Figure 2. LepR+ Cells Contain Most of the CFU-Fs in Adult Bone Marrow and Are the Major Source of New Bone in Adult Mice
(A) Percentage of all CFU-F colonies that were labeled by conditional reporter expression when cultured from enzymatically dissociated bone marrow of the
indicated genotypes. Macrophage colonies were excluded by staining with anti-CD45 antibody in all experiments. n = 3–11 mice/genotype from at least three
independent experiments.
(B) Percentage of bone marrow cells expressing each marker that formed CFU-F colonies in culture (n = 3–5 mice/genotype from at least three independent
experiments).
(legend continued on next page)
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Leptin Receptor Marks Bone Marrow MSCs(Tomato+) bone, stromal cells, and adipocytes in addition to
host-derived CD45+ hematopoietic cells (Figures S2L and
S2M). Cells from the three ossicles that contained the most
hematopoietic cells gavemultilineage reconstitution of irradiated
mice, demonstrating the presence of primitive hematopoietic
progenitors (data not shown).
When bone marrow cells were obtained from the femurs
and tibias of Prx1-cre; tdTomato conditional reporter mice, all
CFU-F colonies formed by unfractionated bone marrow cells
were Tomato+ (Figure 2A). In 2- to 4-month-old Prx1-cre;
tdTomato mice, 8.6% ± 4.0% of all Tomato+ bone marrow cells
(Figure 2B) and 10% ± 3% of Tomato+CD45Ter119 bone
marrow stromal cells formed CFU-F colonies (Figure 2C). Nearly
all LepR+ antibody stained cells were Tomato+ in Prx1-cre;
tdTomatomice and nearly all Tomato+ cells were LepR+ (Figures
S2P and S2Q). Thus, LepR+ cells in the marrow of limb bones
uniformly express the MSC marker Prx1.
Consistent with the conclusion that MSCs secrete factors that
promote HSCmaintenance (Me´ndez-Ferrer et al., 2010; Omatsu
et al., 2010; Sacchetti et al., 2007), both Scf-GFP+ bone marrow
cells and Cxcl12-DsRedhigh bone marrow cells were highly en-
riched for CFU-Fs (Figures 2B and 2C). The observation that
these cells are similarly enriched for CFU-F and LepR+ cells is
consistent with our data demonstrating that nearly all cells that
express Scf-GFP or high levels ofCxcl12-DsRed are LepR+ (Fig-
ures S1D and S1E). These data suggest a strong overlap be-
tween LepR+ stromal cells and CAR cells in the bone marrow.
CFU-Fs often expressed Mx1-Cre, consistent with a recent
study (Park et al., 2012). Bone marrow sections from Mx-1-cre;
tdTomato mice showed widespread Tomato expression among
hematopoietic cells, vascular cells, perivascular cells, and bone-
lining osteoblastic cells (Figures S4B–S4D). We found that
37%± 25%of all CFU-F colonies formed byMx-1-cre; tdTomato
bone marrow cells were Tomato+ (Figure 2A) and 46% ± 23% of
all CD45Ter119CD31PDGFRa+ stromal cells were Tomato+
(Figure S4A). Only rare Tomato+ bone marrow cells formed
CFU-F colonies (Figures 2B and 2C) due to widespread recom-
bination among hematopoietic cells and other stromal cells
(Figure S4A).
CFU-Fs rarely expressed NG2-CreER. Only 1.8% ± 1.0% of
CFU-F colonies formed by bone marrow cells from NG2-creER;
tdTomato reportermicewere Tomato+ (Figure 2A). Tomato+ cells
accounted for 0.0026% ± 0.007% of all bone marrow cells in
NG2-creER; tdTomato mice and 8.8% ± 3.6% of these cells(C) Percentage of nonhematopoietic (CD45Ter119) bone marrow cells expressi
from at least three independent experiments). Two-tailed Student’s t tests were
(D) The percentage of CFU-F colonies that arose from Tomato+CD45Ter119CD
Toluidine blue+ chondrocytes, and/or Alizarin red S+ osteoblasts (n = 3 mice from
(E) Development of bone and hematopoiesis in ossicles formed by individual CFU-
tdTomato mice.
(F–I) Representative femur sections from Lepr-cre; tdTomato; Col2.3-GFP mice
osteoblasts with age (three to five mice/age from at least four independent expe
(J) The frequency of Tomato+CD45Ter119CD31Col2.3-GFP bone marrow
change with age. Cells from 6-month-old Col2.3-GFP; tdTomato mice were ne
three to five mice/age from at least three independent experiments.
(K) Percentage of Col2.3-GFP+ osteoblasts that were also Tomato+ in enzymatic
ages. Osteoblasts from age-matchedCol2.3-GFP orCol2.3-GFP; tdTomatomice
t tests were used to assess statistical significance among consecutive ages. *p
(L and M) Percentage of osteoblasts (L) and osteocytes (M) that were Tomato+ in
Cstained positively for the MSC marker PDGFRa (Figure S3A).
Only 9.8% ± 3.4% of Tomato+ bone marrow cells in NG2-creER;
tdTomato; Scf-GFPmice were positive forScf-GFP (Figure S3A).
We observed almost no NG2-CreER-expressing cells among
PDGFRa+ cells or Scf-GFP+ cells in the bone marrow (Figures
S3B–S3D).
In the bone marrow, NG2-creER labeled vascular smooth
muscle cells (Figure S3E) and GFAP+ glia associated with nerve
fibers (Figure S3F), chondrocytes, osteocytes, and rare osteo-
blasts (data not shown). NG2-antibody-stained cells also
included Aggrecan+ chondrocytes (Figure S3G), Col2.3-GFP+
osteoblasts, and osteocytes (Figure S3H) in 2-month-old mice.
Smooth muscle cells (Murfee et al., 2005), peripheral nerve
Schwann cells (Schneider et al., 2001), cartilaginous cells, and
osteoblasts (Fukushi et al., 2003) have all been previously re-
ported to express NG2.
CFU-Fs also rarely expressed Nestin-creER. We did not
detect any EYFP+ CFU-F colonies formed by bone marrow cells
from Nestin-creER; loxp-EYFP mice (Figure 2A). We observed
labeling of rare cells associated with some arterioles in the
bone marrow of Nestin-creER; loxp-EYFP mice (Figure S4F)
consistent with previously published images (Me´ndez-Ferrer
et al., 2010). EYFP+ cells accounted for 0.0012% ± 0.0005%
of bone marrow cells and were nearly uniformly negative for
PDGFRa (Figure S4E). When we aged Nestin-creER; loxp-
EYFP mice for 11 months, we only detected rare EYFP+
osteoblasts (Figure S4F), demonstrating that Nestin-CreER-
expressing cells are not a significant source of bone in vivo.
The observation that Nestin-GFP+ cells included CFU-Fs, but
that Nestin-CreER-expressing cells did not (Figures 2C and
S1H), is consistent with our observation that different Nestin
transgenes exhibit different expression patterns in the bone
marrow (Ding et al., 2012). Neither Nestin-GFPlow nor Nestin-
GFPhigh bone marrow cells appear to express endogenous
Nestin (see microarray data in Me´ndez-Ferrer et al., 2010 and
RNaseq data in Kunisaki et al., 2013).
CFU-Fs were not neural crest-derived based on fate mapping
with Wnt1-Cre (Chai et al., 2000; Echelard et al., 1994; Joseph
et al., 2004). We observed Tomato+ nerve fibers and glia in the
bonemarrow ofWnt1-cre; tdTomatomice (Figure S4H), confirm-
ing that neural-crest-derived cells were marked in the bone
marrow. In 2- to 4-month-old Wnt1-cre; tdTomato mice,
0.17% ± 0.29% of all Tomato+ bone marrow cells (Figure 2B)
and 0.5% ± 0.5% of Tomato+CD45Ter119 cells (Figure 2C)ng eachmarker that formed CFU-F colonies in culture (n = 3–11mice/genotype
used to assess statistical significance. *p < 0.05, **p < 0.01, ***p < 0.001.
31 cells from Lepr-cre; tdTomatomice that gave rise to Oil red O+ adipocytes,
three independent experiments).
F colonies that arose from LepR+ stromal cells from fourCol2.3-GFP; Lepr-cre;
of different ages showing the increasing generation of Tomato+Col2.3-GFP+
riments).
stromal cells in the femurs of Lepr-cre; tdTomato; Col2.3-GFP mice did not
gative controls (CON). Data in all remaining panels represent mean ± SD from
ally dissociated bone from Lepr-cre; tdTomato; Col2.3-GFP mice of different
were used as negative controls in each experiment (CON). Two-tailed Student’s
< 0.05, **p < 0.01, ***p < 0.001.
bone sections from Lepr-cre; tdTomato; Col2.3-GFP mice.





Figure 3. LepR+ Cells Give Rise to Most Bone Marrow Adipocytes
but Few Chondrocytes
(A) Representative femur sections from a 2-month-old Lepr-cre; tdTomato
mouse. Perilipin+ adipocytes in the bone marrow did not stain with an anti-
LepR antibody (purple) but were Tomato+ (red). Periosteal adipocytes (arrows)
were uniformly Tomato (representative of four mice from four independent
experiments).
(B and C) Quantification of adipocyte number per 7 mm femur section (B) and
the percentage of adipocytes that were Tomato+ at each age (C) in Lepr-cre;
tdTomato mice. Two-tailed Student’s t tests were used to assess statistical
significance. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001. n = 3–5mice/
age from at least three independent experiments. Data represent mean ± SD.
(D and E) Aggrecan+ chondrocytes were not Tomato+ in P0.5 (D) or 2-month-
old (E) Lepr-cre; tdTomato mice (n = 3–5 mice/age from at least three inde-
pendent experiments).
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formed by unfractionated bone marrow cells from Wnt1-cre;
tdTomato reportermicewere Tomato+ (Figure 2A). Tomato+ cells
in the bone marrow of 2-month-oldWnt1-cre; tdTomato reporter
mice accounted for only 0.0017% ± 0.001% of bone marrow160 Cell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc.cells and were mostly negative for the MSC marker PDGFRa
(Figure S4G). We aged Wnt1-cre; tdTomato mice for 5 months
and observed rare Tomato+ osteocytes (Figure S4H) but no
Tomato+ osteoblasts, indicating that these cells are not a signif-
icant source of bone-forming progenitors in young adult mice.
LepR+ Cells Are a Major Source of Bone in Adult Mice
LepR+ cells arose perinatally in bone marrow and made little
bone before 2 months of age. We fate mapped the LepR+ cells
in vivo using Lepr-cre; tdTomato; Col2.3-GFP mice in which
osteoblastic bone-lining cells can be unambiguously identified
based on Col2.3-GFP expression (Kalajzic et al., 2002). At em-
bryonic day (E) 19.5, Tomato+ cells were rare in the bonemarrow
of Lepr-cre; tdTomato; Col2.3-GFP mice and we observed no
contribution of these cells to bone (Figure 2F). By postnatal
day (P) 0.5, there was a sharp increase in the number of Tomato+
cells in metaphyseal bone marrow, though Tomato+ cells re-
mained rare in the diaphyseal bone marrow and only rare
Tomato+Col2.3-GFP+ osteoblasts were observed in trabecular
bone (Figure 2G). By 2 months of age, Tomato+ cells were visible
throughout the bone marrow in both metaphysis and diaphysis,
but Tomato+Col2.3-GFP+ cells remained infrequent (Figure 2H),
accounting for 3%–10% of Col2.3-GFP+ cells in several bones
(Figure 2K). However, the contribution of LepR+ cells to bone
increased sharply with age. Tomato+ cells accounted for 10%–
23% of Col2.3-GFP+ cells in several bones at 6 months of age,
43%–67% of Col2.3-GFP+ cells at 10 months of age, and
61%–81% of Col2.3-GFP+ cells at 14 months of age (Figures
2K and S2R). The increased frequency of Tomato+Col2.3-GFP+
cells was not caused by the induction of Lepr expression within
Col2.3-GFP+ osteoblastic cells (Figures S2S and S2T).
By 10 months of age, Tomato+ cells contributed not only to
bone-lining osteoblastic cells but also to osteocytes within the
bone matrix (Figure 2Iiii). The percentage of osteocytes that
were Tomato+ increased significantly with age, but much more
rapidly within trabecular bone (Figure 2M). Tomato+ cells repre-
sented 92% ± 7% of osteocytes in trabecular bone and 13% ±
5% of osteocytes in cortical bone at 14 months of age.
LepR+ Cells Are a Major Source of Adipocytes in Adult
Bone Marrow
Although LepR antibody did not detectably stain Perilipin+
adipocytes (Figures 1J and 3A), most Perilipin+ adipocytes in
the bone marrow of 2- to 14-month-old Lepr-cre; tdTomato
mice were Tomato+ (Figures 3A–3C). The number of adipocytes
in the bone marrow increased dramatically with age (Figure 3B).
In contrast to those in the bone marrow, periosteal adipocytes
(outside of the marrow cavity) were all negative for Tomato (Fig-
ure 3A), suggesting a distinct cellular origin. LepR+ cells are thus
the major source of adipocytes in adult bone marrow.
Chondrogenesis is active during fetal development but largely
inactive throughout adulthood (Raghunath et al., 2005). In mice
at P0.5 and at 2 months of age, we detected no Tomato expres-
sion among Aggrecan+ chondrocytes in the femurs of Lepr-cre;
tdTomato mice (Figure 3D) in spite of Tomato+ osteoblasts and
perivascular stromal cells adjacent to the growth plate (Fig-
ure 3E). In 6-, 10-, and 14-month-old mice, we remained unable
to detect Tomato+ chondrocytes in articular cartilage or growth
plate cartilage associated with femurs and tibias (Figure S5A
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Figure 4. LepR+Col2.3-GFP– Cells Are Quiescent under Normal Physiological Conditions in Adult Bone Marrow but Go into Cycle to
Regenerate Bone after Injury
(A–C) BrdU incorporation (14 day pulse) (A and B) or Hoechst staining (C) by various stromal cell fractions from enzymatically dissociated bone and bone marrow
obtained from 2-month-old Lepr-cre; tdTomato; Col2.3-GFP mice. Unless otherwise indicated, data in all remaining panels represent mean ± SD from three or
four mice in three independent experiments, with statistical significance assessed by two-tailed Student’s t tests. ns, not significant; *p < 0.05, **p < 0.01,
***p < 0.001.
(D) Percentage of Tomato+Col2.3-GFPCD45Ter119CD31 bone marrow stromal cells that incorporated a 14 day pulse of BrdU.
(E) Percentage of Tomato+CD45Ter119CD31 bone marrow stromal cells that incorporated a 14 day pulse of BrdU in femurs and tibias from Lepr-cre;
tdTomato mice and Lepr-cre; tdTomato; iDTR mice 2 weeks after diphtheria toxin (DT) treatment.
(F) Bone marrow cellularity in the femurs and tibias of Lepr-cre; tdTomato; iDTR mice at the indicated time points after DT treatment.
(G) Number of Tomato+CD45Ter119CD31 stromal cells in bone marrow from Lepr-cre; tdTomato; iDTR mice after DT treatment.
(H) Number of CD150+CD48LineageSca-1+c-kit+ HSCs in the femurs and tibias 7 days after DT treatment.
(legend continued on next page)
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with age of Tomato+ cells to a layer of Aggrecan cells on the
cartilage surface that appeared to be part of the synovial mem-
brane (Figures S5Ai and S5B). We do not knowwhether Tomato+
synovial cells are lineally related to LepR+ bone marrow stromal
cells. Overall, we observed little contribution of LepR+ cells to
cartilage.
LepR+ Bone Marrow Stromal Cells Are Quiescent
We administered bromo-deoxyuridine (BrdU) to 2-month-old
Lepr-cre; tdTomato; Col2.3-GFP mice for 14 days. We found
that 94% ± 2.4% of TomatoCol2.3-GFP stromal cells were
BrdU+, 27% ± 8.9% of TomatoCol2.3-GFP+ osteoblasts were
BrdU+, and 55% ± 12% of Tomato+Col2.3-GFP+ osteoblasts
were BrdU+, but only 4.8% ± 1.1% of Tomato+Col2.3-GFP
stromal cells were BrdU+ (Figures 4A and 4B). Consistent with
this, only 0.23% ± 0.3% of Tomato+Col2.3-GFP stromal cells
had greater than 2N DNA content by Hoechst staining (Fig-
ure 4C). LepR+ stromal cells are thus largely quiescent in normal
adult bone marrow.
At 2 months of age, the LepR+ cells gave rise to osteoblasts
and adipocytes to a much greater extent in metaphyseal bone
marrow than in diaphyseal bone marrow (Figures 2H, 2L, and
3A). Tomato+Col2.3-GFP cells from the metaphysis incorpo-
rated a 14-day pulse of BrdU at nearly three times the rate of
Tomato+Col2.3-GFP cells from the diaphysis (Figure 4D).
Thus, there is regional regulation of LepR+ stromal cells in the
bone marrow.
We ablated LepR+ bone marrow cells by administering DT to
Lepr-cre; tdTomato; Rosa26-loxP-stop-loxP-iDTR (inducible
DT receptor) mice and littermate controls. In contrast to DT-
treated controls (lacking iDTR), in which only 8.2% ± 2.0%
of Tomato+Col2.3-GFP bone marrow stromal cells in-
corporated a 14-day pulse of BrdU, 89% ± 4.5% of Tomato+
CD45Ter119CD31 cells from Lepr-cre; tdTomato; iDTR
mice incorporated BrdU (Figure 4E). Bone marrow cellularity
and the number of Tomato+ stromal cells in the bone marrow
declined significantly 1 day after DT treatment but rebounded
within 2 weeks (Figures 4F and 4G). Consistent with our demon-
stration that LepR+ stromal cells are critical for the maintenance
of quiescent HSCs (Ding and Morrison, 2013; Ding et al., 2012;
Oguro et al., 2013), DT treatment depleted CD150+CD48LSK
HSCs (Figure 4H).
Within 14 days of DT treatment, adipogenesis (Figure 4J) and
osteogenesis (Figure 4K) increased profoundly in the bone
marrow. Trabecular bone began filling up the marrow cavity,
including the diaphysis (Figure 4M). Virtually all of the bone
marrow adipocytes as well as the new Col2.3-GFP+ osteoblasts
were Tomato+ (Figures 4J–4L). The rate of bone formation, as(I and J) Quantification of adipocyte number per 7 mm femur section (I) and the p
(K) Percentage of Col2.3-GFP+ osteoblasts that were also Tomato+ in enzymatic
(L) Percentage of Col2.3-GFP+ osteoblasts that were also Tomato+ at metaphys
(M) Representative femur sections from Lepr-cre; tdTomato; Col2.3-GFP; iDTRmi
by Tomato+Col2.3-GFP+ cells in the diaphyseal bone marrow cavity (Mii).
(N and O) Bone formation rate in Lepr-cre; iDTR and control mice after DT treatme
distance between calcein bands was measured at 14 days after DT treatment.
(P) Osteoclasts (arrow) were not labeled by Tomato in Lepr-cre; tdTomato mice.
(Q) Percentage of Tomato+CD45Ter119CD31 bonemarrow stromal cells that i
after irradiation. n = 3–5 mice/time point from three independent experiments.
162 Cell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc.measured by calcein labeling, was significantly higher in Lepr-
cre; tdTomato; iDTR mice as compared to controls in both the
metaphysis and the diaphysis (Figures 4N and 4O). LepR+ cells
did not give rise to Calcitonin+ osteoclasts (Figure 4P). The
regeneration of LepR+ cells after ablation is thus associated
with increased adipogenesis and osteogenesis.
LepR+ Cells Are Activated by Irradiation to Form
Osteoblasts and Adipocytes
We found that 25%± 2.3%of the Tomato+ stromal cells incorpo-
rated BrdU over a 2 week period after irradiation of Lepr-cre;
tdTomato mice (Figure 4Q). In the next 2 weeks after irradiation,
the percentage of Tomato+ stromal cells that incorporated BrdU
significantly increased to 35% ± 5.0% (Figure 4Q). At subse-
quent time points the percentage of Tomato+ stromal cells that
incorporated BrdU significantly declined (Figure 4Q). LepR+ cells
therefore divide transiently after irradiation. We observed a sub-
stantial increase in adipocyte frequency within the bone marrow
after irradiation (Figure 5A) and 95% ± 3.0% of the Perilipin+
adipocytes were Tomato+ (Figure 5B). The frequency of osteo-
blasts undergoing cell death significantly increased 2 days after
irradiation (Figure 5C). By 16weeks after irradiation, most (65%±
11%) osteoblasts derived from LepR+ cells (Figure 5D and Fig-
ure S6A). Irradiation did not activate LepR expression in osteo-
blasts (Figures S6B and S6C). We remained unable to detect
any contribution of LepR+ cells to chondrocytes after irradiation
(Figure S6D and data not shown).
Regeneration of Fractured Bone by LepR+ Cells
Two weeks after a break was created in the tibia of two-month-
old Lepr-cre; tdTomato; Col2.3-GFP mice (Figure 5E), a sub-
stantial increase of Tomato+ stromal cells was observed in the
marrow cavity adjacent to the fracture site (Figure 5F). Col2.3-
GFP+ cells close to periosteum were mostly negative for Tomato
expression, but much of the callus was composed of Tomato+
cells (Figure 5F). Tomato+ cells accounted for 46% ± 13% of
Aggrecan+ chondrocytes in the soft callus 2 weeks following
the fracture (Figures 5I and 5J). At 2 and 8 weeks after the frac-
ture, 45% ± 5% and 85% ± 10% of Col2.3-GFP+ osteoblasts
were Tomato+ (Figures 5F–5H). In contrast, only 9%–14% of
Col2.3-GFP+ osteoblasts were Tomato+ in the undamaged tibia
of the same mice (Figure 5H). We confirmed by qRT-PCR
that Ob–Rb mRNA was not expressed by newly generated
osteoblasts at the tibia fracture site (Figure S6E). Most of the
osteoblasts and osteocytes that persisted long-term at the frac-
ture site thus arose from LepR+ cells.
To investigate the contribution of LepR+ cells to the repair of
perforated cartilage, we performed a subchondral perforation
in articular cartilage associated with the femur in the knee ofercentage of adipocytes that were Tomato+ (J) 14 days after DT treatment.
ally dissociated bone 2 weeks after DT treatment.
eal (Met) and diaphyseal (Dia) bones 2 weeks after diphtheria toxin treatment.
ce at 2 weeks after DT treatment. Note the formation of ectopic trabecular bone
nt. Two doses of calcein were injected at day 0 and 7 after DT treatment and the
ncorporated a 14 day pulse of BrdU in Lepr-cre; tdTomatomice at various times
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Figure 5. LepR+ Cells Are the Major Source of New Osteoblasts and Adipocytes during Tissue Regeneration and Can also Form Chondro-
cytes after Subchondral Perforation
(A and B) Representative femur section from a 2-month-old Lepr-cre; tdTomato mouse 14 days after lethal irradiation and transplantation of wild-type bone
marrow cells. Perilipin+ adipocytes in the bone marrow did not stain with an anti-LepR antibody (purple) but were Tomato+ (red), demonstrating that they derived
from endogenous radio-resistant LepR+ cells (mean ± SD from five mice in four independent experiments).
(C) Percentage ofCol2.3-GFP+ osteoblasts that were also DAPI+Annexin V+ in enzymatically dissociated bone 2 days after irradiation. Data in all remaining panels
represent mean ± SD from three or four mice (per time point) in three independent experiments.
(D) Percentage ofCol2.3-GFP+ osteoblasts that were also Tomato+ in enzymatically dissociated bone from Lepr-cre; tdTomato; Col2.3-GFPmice at various time
points after irradiation.
(E) Schematic of experimental fracture site. The black rectangle depicts the region shown in images in (G), (H), and (J).
(F and G) Tomato expression byCol2.3-GFP+ osteoblasts at the fracture site in Lepr-cre; tdTomato; Col2.3-GFPmice at 2 weeks (F) or 8 weeks (G) after fracture.
(H) Percentage of Col2.3-GFP+ osteoblasts that were also Tomato+ in unfractured tibias from control mice (normal) and bone callus from Lepr-cre; tdTomato;
Col2.3-GFP mice.
(I and J) Percentage of Aggrecan+ chondrocytes that were also Tomato+ at the fracture site 2 weeks after the fracture.
(K and L) Percentage of Aggrecan+ chondrocytes that were also Tomato+ 8 weeks after subchondral perforation of articular cartilage in Lepr-cre; tdTomatomice.
Statistical significance was always assessed using two-tailed Student’s t tests. ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 6. LepR+ Cells Give Rise to Osteoblasts, Adipocytes, and
Chondrocytes after Intrafemoral Transplantation
(A) Experimental design.
(B–D) Representative femur sections from Col2.3-GFPmice transplanted with
500 Tomato+Col2.3-GFP cells as described in (A) (n = 5). Note that the
transplanted Tomato+Col2.3-GFP cells gave rise toCol2.3-GFP+ osteoblasts
(B), Perilipin+ adipocytes (C), and Aggrecan+ cartilage cells (at the injection
site, D).
(E) Fraction of recipient mice in which Tomato+ cells were observed to
contribute to each of the indicated mesenchymal lineages (n = 12 mice).
(F) The percentage of LepR+ bone marrow stromal cells or Col2.3-GFP+
osteoblasts that were also Tomato+ (donor-derived) in the femurs of recipient
mice (mean ± SD from three mice in three independent experiments).
(G) No Tomato+LepR+ cells or Tomato+Col2.3-GFP+ cells were observed in the
femurs ofmice transplantedwith 105 nonhematopoieticCol2.3-GFPTomato
cells from Lepr-cre; tdTomato; Col2.3-GFP mice (n = 3).
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injured region of the cartilage was covered by Aggrecan+ fibro-
cartilaginous tissues (Figure 5K) and 16% ± 11% of the
Aggrecan+ cells were positive for Tomato expression (Figures
5K and 5L). Thus, LepR+ cells form cartilage after injury even
though they contribute little to the formation of cartilage during
development.
LepR+ Cells Form Bone, Cartilage, and Adipocytes after
Transplantation
We transplanted 500 Tomato+Col2.3-GFP cells from Lepr-cre;
tdTomato; Col2.3-GFP mice into sublethally irradiated Col2.3-
GFPmice by intrafemoral injection (Figure 6A). Four weeks later,
Tomato expression was observed in Col2.3-GFP+ osteoblasts
(Figure 6B), Perilipin+ adipocytes (Figure 6C), and Aggrecan+
chondrocytes in articular cartilage (which had been perforated
by the injection; Figure 6D). Of 12 recipient femurs, 5 contained
trilineage reconstitution by transplanted Tomato+ cells, 2 con-
tained Tomato+ osteolineage cells and adipocytes, but not
cartilage, and 5 contained only Tomato+ osteolineage cells (Fig-
ure 6E). In an independent experiment in which engraftment was
analyzed by flow cytometry, Tomato+ cells accounted for 1.3%±
1.4% of LepR+ cells and 3.2% ± 1.2% of Col2.3-GFP+ cells in
recipient femurs (Figure 6F). In contrast, transplantation of
105 TomatoCol2.3-GFPCD45Ter119 stromal cells did not
generate any Tomato+ or Col2.3-GFP+ cells (Figure 6G), sug-
gesting that LepR bone marrow cells have little capacity to
form mesenchymal derivatives.
PTEN Regulates Quiescence, Maintenance, and
Differentiation of LepR+ Cells
Pten is cell-autonomously required for the maintenance of HSCs
(Kalaitzidis et al., 2012; Lee et al., 2010; Magee et al., 2012;
Yilmaz et al., 2006; Zhang et al., 2006) and neural stem cells
(Bonaguidi et al., 2011). To assess the consequences of Pten
deletion from MSCs, we generated Lepr-cre; Ptenfl/fl mice. As
expected, AKT (S473) phosphorylation increased in LepR+ stro-
mal cells isolated from Lepr-cre; Ptenfl/fl mice (Figure 7A). Body
mass and bone marrow cellularity were normal in Lepr-cre;
Ptenfl/fl mice (Figures 7B and 7C). However, we observed a
more than 2-fold reduction in the frequencies of LepR+
CD45Ter119CD31 stromal cells (Figure 7D), PDGFRa+
CD45Ter119CD31 stromal cells (Figure 7E), and CFU-Fs
(Figure 7F) in Lepr-cre; Ptenfl/fl mice relative to littermate con-
trols. Based on BrdU incorporation, LepR+ cells divided more
frequently in Lepr-cre; Ptenfl/flmice relative to littermate controls
(Figure 7G). Pten is thus cell-autonomously required to nega-
tively regulate AKT activation and to maintain normal numbers
of quiescent LepR+ MSCs in adult bone marrow.
Four-month-old Lepr-cre; Ptenfl/fl mice had a decreased
volume of trabecular and cortical bone (Figures 7H–7P)
but increased adipogenesis in the metaphysis relative to
littermate controls (Figure 7Q). The expression of Runx2, a
transcription factor required for osteogenesis (Komori et al.,
1997; Otto et al., 1997), was markedly reduced in LepR+ stromal
cells from Lepr-cre; Ptenfl/fl as compared to control mice
(Figure 7R). Pten deletion did not affect the percentage of
CFU-F colonies that contained adipocytes versus osteoblastic
cells (Figure 7S), but it did significantly increase the number of
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Figure 7. PTEN Regulates Quiescence, Maintenance, and Differentiation in LepR+ Stromal Cells
(A) Representative western blots of flow cytometrically isolated LepR+CD45Ter119CD31 stromal cells from 4-month-old Lepr-cre; Ptenfl/flmice and littermate
controls.
(B) Bodymass. (Unless otherwise indicated, all remaining panels showmean ±SD from three to fivemice in three to four independent experiments, with statistical
significance assessed by two-tailed Student’s t tests; ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.)
(C) Bone marrow cellularity in the femurs of 4-month-old Lepr-cre; Ptenfl/fl mice and littermate controls.
(D) Number of LepR+CD45Ter119CD31 cells.
(E) Number of PDGFRa+CD45Ter119CD31 cells.
(legend continued on next page)
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alkaline phosphatase+ osteogenic cells that spontaneously
differentiated within these colonies (Figure 7T). Pten is thus
required by LepR+ cells to promote osteogenesis and to restrain
adipogenesis.
We did not detect a decline in the frequency of HSCs (Fig-
ure 7U) or colony-forming hematopoietic progenitors (Figure 7W
and Figures S7B–S7F) in the bone marrow of Lepr-cre; Ptenfl/fl
mice. Bone marrow cells from Lepr-cre; Ptenfl/fl and control
mice gave similar levels of donor cell reconstitution upon trans-
plantation into irradiated mice (Figures 7V and S7A). Nonethe-
less, we did observe significant increases in the frequencies of
HSCs (Figure 7U) and colony-forming hematopoietic progenitors
(Figure 7W) in the spleen. These data suggest that Pten deletion
from LepR+ bone marrow stromal cells changed the bone
marrow niche in a way that led to the mobilization of HSCs and
colony-forming progenitors.
DISCUSSION
Our data support the conclusion that MSCs are an important
component of the HSC niche (Kunisaki et al., 2013; Me´ndez-
Ferrer et al., 2010; Omatsu et al., 2010; Sacchetti et al., 2007)
because LepR+ stromal cells are a major source of HSC niche
factors in addition to MSC activity. Nearly all Scf-GFP+ bone
marrow stromal cells and Cxcl12-DsRedhigh bone marrow stro-
mal cells were LepR+ (Figures 1C, 1E, S1E, and S1F). The high
expression of Cxcl12 (Figure S1E) and PDGFRa (Figures 1L
and 1M) by LepR+ stromal cells indicates that these cells overlap
strongly with CAR cells, which are also found primarily around
sinusoids throughout the bone marrow (Omatsu et al., 2010;
Sugiyama et al., 2006). However, our data indicate that NG2-
CreER-expressing cells are not a significant source of MSCs in
the bone marrow. NG2-CreER-expressing cells were much
more rare than Scf-GFP+ cells or Cxcl12-DsRed+ cells (Figures
S1E, S1F, and S3A–S3C) and we observed little PDGFRa or
Scf-GFP expression by these cells (Figures S3A–S3D). While
Kunisaki et al. (2013) concluded that NG2+NestinhighLepR peri-
arteriolar cells express high levels of Scf and Cxcl12, their
RNaseq analysis showed that the ‘‘NestinhighLepR’’ cells they
analyzed were negative for Nestin and positive for Lepr expres-
sion (see GSE48764 in the Gene Expression Omnibus, refer-
enced by Kunisaki et al., 2013). Thus, the data from Kunisaki(F) CFU-Fs per million bone marrow cells.
(G) Percentage of LepR+CD45Ter119CD31 bone marrow stromal cells that in
(H–O) MicroCT measurement of cortical (Ct) thickness (H), cortical area (I), total (T
total volume (BV/TV) (L), trabecular number (M), trabecular thickness (N), and tra
(P) Representative microCT images of femurs.
(Q) Representative femur sections showing excessive adipogenesis at metaphys
(R) qPCR analysis of transcript levels for genes associated with osteogenic or adip
based on b-actin amplification then set to 1 in control samples for comparison p
(S) The percentage of CFU-F colonies that contained adipocytes (Oil red O+) and
3 weeks.
(T) The average number of Perilipin+ adipocytes or Alkaline phosphatase+ (ALP+) o
for 1 week in standard medium.
(U) Number of CD150+CD48LineageSca-1+c-kit+ HSCs in the bone marrow an
(V) Donor-cell engraftment when 33 105 donor bonemarrow cells were transplant
(n = 11–12 recipient mice per genotype in three experiments).
(W) Frequencies of myeloerythroid-colony-forming progenitors in the bone marro
166 Cell Stem Cell 15, 154–168, August 7, 2014 ª2014 Elsevier Inc.et al. are consistent with our data indicating that cells with high
levels ofScf andCxcl12 in the bonemarrow aremarked by LepR.
EXPERIMENTAL PROCEDURES
Mice
All mice were maintained in a C57BL/6 background, including Lepr-cre
(DeFalco et al., 2001), Leprfl/fl (Cohen et al., 2001), Ptenfl/fl (Groszer et al.,
2001), Scf-GFP (Ding et al., 2012), Cxcl12-DsRed (Ding and Morrison, 2013),
Ubc-creER (Ruzankina et al., 2007), Rosa26-CAG-loxp-stop-loxp-tdTomato
(Madisen et al., 2010), Rosa26-loxp-stop-loxp-EYFP (Srinivas et al., 2001),
Rosa26-loxp-stop-loxp-iDTR (Buch et al., 2005), NG2-creERTM (Zhu et al.,
2011), Wnt-1-cre (Danielian and McMahon, 1996), Nestin-GFP (Mignone
et al., 2004), Nestin-creER (Balordi and Fishell, 2007), Mx-1-cre (Ku¨hn et al.,
1995), and Col2.3-GFP (Kalajzic et al., 2002) mice. To induce CreER activity,
male mice (>2-month-old) were injected with 1 mg tamoxifen (Sigma) daily
for 5 consecutive days followed by being fed ab libidum with chow containing
400 mg/kg tamoxifen for at least 2 weeks. To induceMx-1-Cre expression, 2-
month-old mice were injected with 10 mg poly-inosine:poly-cytosine (pIpC;
Amersham)/20 g body mass every other day for 10 days. To treat mice with
DT, we injected mice intraperitoneally with 100 ng of DT for 7 consecutive
days. All mice were housed in the Animal Resource Center at the University
of Texas SouthwesternMedical Center (UTSW). All procedureswere approved
by the UTSW Institutional Animal Care and Use Committee.
For methods related to flow cytometry, bone sectioning, qPCR, culture
assay conditions, ossicle formation, irradiation, cell cycle analysis, calcein
labeling, micro CT, western analysis, bone fracturing, intrafemoral injection,
and subchondral perforation, see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
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